miércoles, 24 de enero de 2024

Prescripción electrónica en UK: Rybelsus (semaglutida) se ha añadido mareo como nuevo efecto adverso en todas las presentaciones.

 https://www.medicines.org.uk/emc/product/14389/smpc

  Clinical particulars

4.1 Therapeutic indications
4.2 Posology and method of administration
4.3 Contraindications
4.4 Special warnings and precautions for use
4.5 Interaction with other medicinal products and other forms of interaction
4.6 Fertility, pregnancy and lactation
4.7 Effects on ability to drive and use machines
4.8 Undesirable effects
4.9 Overdose

No hay comentarios:

Publicar un comentario